Enfusion, Inc. (ENFN)

NYSE: ENFN · Real-Time Price · USD
10.63
+0.16 (1.53%)
Dec 20, 2024, 4:00 PM EST - Market closed
1.53%
Market Cap 1.37B
Revenue (ttm) 195.16M
Net Income (ttm) 2.73M
Shares Out 128.57M
EPS (ttm) 0.03
PE Ratio 500.99
Forward PE 39.68
Dividend n/a
Ex-Dividend Date n/a
Volume 294,151
Open 10.28
Previous Close 10.47
Day's Range 10.22 - 10.74
52-Week Range 7.52 - 11.38
Beta 0.98
Analysts Hold
Price Target 9.80 (-7.81%)
Earnings Date Nov 4, 2024

About ENFN

Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, an... [Read more]

Sector Technology
IPO Date Oct 21, 2021
Employees 1,102
Stock Exchange NYSE
Ticker Symbol ENFN
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 5 analysts, the average rating for ENFN stock is "Hold." The 12-month stock price forecast is $9.8, which is a decrease of -7.81% from the latest price.

Price Target
$9.8
(-7.81% downside)
Analyst Consensus: Hold
Stock Forecasts

News

Orbus Software Announces Strategic Growth Investment from FTV Capital and SilverTree Equity

NEW YORK & LONDON--(BUSINESS WIRE)-- #DigitalTransformation--Orbus Software announces strategic growth investment from FTV Capital and SilverTree Equity.

Other symbols: GLOB
5 days ago - Business Wire

Enfusion To Present at Upcoming Investor Events

NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, today announced that Enf...

4 weeks ago - Business Wire

Enfusion, Inc. (ENFN) Q3 2024 Earnings Call Transcript

Enfusion, Inc. (NYSE:ENFN) Q3 2024 Earnings Conference Call November 4, 2024 8:30 AM ET Company Participants Bill Wright - Head, IR Oleg Movchan - Chief Executive Officer Bradley Herring - Chief Fina...

6 weeks ago - Seeking Alpha

Enfusion Announces Third Quarter 2024 Results

NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, has posted its third qua...

6 weeks ago - Business Wire

Enfusion Announces Key Leadership Team Additions to Drive Client Success and Fuel Innovation

NEW YORK--(BUSINESS WIRE)--Enfusion, Inc. (“Enfusion”) (NYSE: ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, announced today the appointments of Arman Art...

2 months ago - Business Wire

FTV Capital and One Mind at Work Launch Partnership to Support Mental Health Within High-Growth Companies

SAN FRANCISCO & RUTHERFORD, Calif.--(BUSINESS WIRE)--FTV Capital, a leading sector-focused growth equity firm, and One Mind at Work, a global nonprofit dedicated to building the future of workforce me...

Other symbols: GLOB
2 months ago - Business Wire

Enfusion Announces Date of Third Quarter 2024 Results

NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, today announced it will ...

2 months ago - Business Wire

The Schall Law Firm Invites Investor Participation In An Inquiry Into Enfusion Inc For Violating Securities Laws

LOS ANGELES, CA / ACCESSWIRE / October 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Enfusion, Inc. ...

2 months ago - Accesswire

Enfusion, Inc. Is Being Looked Into For Possible Securities Fraud And Affected Shareholders Are Urged To Contact The Schall Law Firm

LOS ANGELES, CA / ACCESSWIRE / October 1, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Enfusion, Inc. ...

2 months ago - Accesswire

The Schall Law Firm Invites Investors To Help Investigate Whether Enfusion Inc Violated Securities Laws

LOS ANGELES, CA / ACCESSWIRE / September 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Enfusion, In...

2 months ago - Accesswire

Shareholders Are Encouraged To Join The Schall Law Firm's Inquiry Into Enfusion, Inc. For Possible Securities Fraud

LOS ANGELES, CA / ACCESSWIRE / September 29, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Enfusion, In...

2 months ago - Accesswire

Enfusion Inc Is Being Investigated For Violating Securities Laws And The Schall Law Firm Seeks Investor Participation

LOS ANGELES, CA / ACCESSWIRE / September 28, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Enfusion, In...

3 months ago - Accesswire

The Schall Law Firm Is Inquiring Into Enfusion, Inc. For Possible Securities Fraud And Stockholders With Losses Should Take Part

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Enfusion, Inc. ("Enfusion" or "the Company") (NYSE:ENFN) for vio...

3 months ago - Accesswire

Enfusion Inc May Have Violated Securities Laws And The Schall Law Firm Wants Impacted Investors To Reach Out

LOS ANGELES, CA / ACCESSWIRE / September 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Enfusion, In...

3 months ago - Accesswire

Shareholders Are Urged To Join The Schall Law Firm's Investigation Into Enfusion, Inc. For Possible Securities Fraud

LOS ANGELES, CA / ACCESSWIRE / September 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Enfusion, In...

3 months ago - Accesswire

VALD Secures Significant Growth Equity Investment from FTV Capital

BRISBANE, Australia--(BUSINESS WIRE)--VALD, a global health technology company and the system of choice for musculoskeletal (“MSK”) health professionals, today announced a significant growth equity in...

Other symbols: GLOB
3 months ago - Business Wire

Enfusion Inc Is Being Looked Into For Violating Securities Laws And The Schall Law Firm Invites Investors To Reach Out

LOS ANGELES, CA / ACCESSWIRE / September 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Enfusion, In...

3 months ago - Accesswire

The Schall Law Firm Is Investigating Enfusion, Inc. For Possible Securities Fraud And Affected Shareholders Are Urged To Lend A Hand

LOS ANGELES, CA / ACCESSWIRE / September 23, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Enfusion, In...

3 months ago - Accesswire

Enfusion Inc May Have Violated Securities Laws And The Schall Law Firm Wants Investors With Losses To Help With An Inquiry

LOS ANGELES, CA / ACCESSWIRE / September 22, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Enfusion, In...

3 months ago - Accesswire

The Schall Law Firm Is Looking Into Enfusion, Inc. For Possible Securities Fraud And Shareholders Are Urged To Take Part

LOS ANGELES, CA / ACCESSWIRE / September 21, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Enfusion, In...

3 months ago - Accesswire

Exclusive: Financial software maker Enfusion explores options including sale, sources say

Enfusion , a U.S. software provider for asset managers, is in talks with investment bankers to evaluate its options that could include a potential sale, according to people familiar with the matter.

3 months ago - Reuters

Enfusion Inc May Have Violated Securities Regulations And The Schall Law Firm Encourages Investor Participation In An Inquiry

LOS ANGELES, CA / ACCESSWIRE / September 20, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Enfusion, In...

3 months ago - Accesswire

The Schall Law Firm Is Looking Into Enfusion, Inc. For Possible Securities Fraud And Affected Stockholders Are Urged To Reach Out

LOS ANGELES, CA / ACCESSWIRE / September 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Enfusion, In...

3 months ago - Accesswire

Enfusion Inc May Have Violated Securities Laws And Investors With Losses Can Join The Schall Law Firm's Investigation

LOS ANGELES, CA / ACCESSWIRE / September 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Enfusion, In...

3 months ago - Accesswire

The Schall Law Firm Is Inquiring Into Enfusion, Inc. For Possible Securities Fraud And Shareholder Participation Is Urged

LOS ANGELES, CA / ACCESSWIRE / September 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Enfusion, In...

3 months ago - Accesswire